Parametric Portfolio Associates’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $15.4M | Buy |
394,985
+25,306
| +7% | +$986K | 0.01% | 1111 |
|
|
2021
Q4 | $14.7M | Buy |
369,679
+54,031
| +17% | +$2.15M | 0.01% | 1143 |
|
|
2021
Q3 | $11.4M | Buy |
315,648
+76,131
| +32% | +$2.75M | 0.01% | 1265 |
|
|
2021
Q2 | $9.82M | Buy |
239,517
+55,889
| +30% | +$2.29M | 0.01% | 1409 |
|
|
2021
Q1 | $8.01M | Buy |
183,628
+5,578
| +3% | +$243K | ﹤0.01% | 1838 |
|
|
2020
Q4 | $8.91M | Buy |
178,050
+158,211
| +797% | +$7.92M | 0.01% | 1657 |
|
|
2020
Q3 | $835K | Buy |
+19,839
| New | +$835K | ﹤0.01% | 3030 |
|